Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maskell

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
BMJ Open|November 10, 2022
Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)Ruairi J H Conway, Jenny Symonds, Deborah Walton, et al.
BMJ Open|December 26, 2024
Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trialSteven Walker, Ellie Taylor, Amy McAndrew, et al.
Respiration; International Review of Thoracic Diseases|November 14, 2017
A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural EffusionsGiles Dixon, Rahul Bhatnagar, Natalie Zahan-Evans, et al.
Pilot and Feasibility Studies|September 3, 2022
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodologyAnna C Bibby, Natalie Zahan-Evans, Emma Keenan, et al.
Annals of the American Thoracic Society|April 12, 2016
Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational StudyOliver J Bintcliffe, Clare E Hooper, Iain J Rider, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2025
Serum mesothelin as a response biomarker in pleural mesotheliomaGeraldine A Lynch, Jenny Symonds, Anna Morley, et al.
Emergency Medicine Journal : EMJ|May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort studyDavid T Arnold, Marie Attwood, Shaney Barratt, et al.
BMJ Open|November 26, 2016
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studySelina Tsim, Caroline Kelly, Laura Alexander, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2019
Survival in patients with malignant pleural effusion undergoing talc pleurodesisMaged Hassan, Rachel M Mercer, Nick A Maskell, et al.
Chest|September 2, 2015
Absence of Atypical Pathogens in Pleural InfectionJohn M Wrightson, Jessica A Wray, Teresa L Street, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
BMJ Open|November 10, 2022
Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)Ruairi J H Conway, Jenny Symonds, Deborah Walton, et al.
BMJ Open|December 26, 2024
Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trialSteven Walker, Ellie Taylor, Amy McAndrew, et al.
Respiration; International Review of Thoracic Diseases|November 14, 2017
A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural EffusionsGiles Dixon, Rahul Bhatnagar, Natalie Zahan-Evans, et al.
Pilot and Feasibility Studies|September 3, 2022
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodologyAnna C Bibby, Natalie Zahan-Evans, Emma Keenan, et al.
Annals of the American Thoracic Society|April 12, 2016
Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational StudyOliver J Bintcliffe, Clare E Hooper, Iain J Rider, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2025
Serum mesothelin as a response biomarker in pleural mesotheliomaGeraldine A Lynch, Jenny Symonds, Anna Morley, et al.
Emergency Medicine Journal : EMJ|May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort studyDavid T Arnold, Marie Attwood, Shaney Barratt, et al.
BMJ Open|November 26, 2016
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studySelina Tsim, Caroline Kelly, Laura Alexander, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2019
Survival in patients with malignant pleural effusion undergoing talc pleurodesisMaged Hassan, Rachel M Mercer, Nick A Maskell, et al.
Chest|September 2, 2015
Absence of Atypical Pathogens in Pleural InfectionJohn M Wrightson, Jessica A Wray, Teresa L Street, et al.
Pageof 22